Evidence that active protection following oral immunization of mice with live rotavirus is not dependent on neutralizing antibody.

No abstract is available for this paper.

• Publication year

  1992

• Venue

  Virology

• Publication date

  1992-05-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1016/0042-6822(92)90734-7PMID 1314467
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Rotavirus infection in lambs: Studies on passive protection

  2005cited by this paper
• A field study of the safety and efficacy of two candidate rotavirus vaccines in a Native American population.

  1991cited by this paper
• Evaluation of WC3 rotavirus vaccine and correlates of protection in healthy infants.

  1991cited by this paper
• Sequential rotavirus infections: characterization of serotypes and electrophoretypes.

  1991cited by this paper
• Murine intestinal antibody response to heterologous rotavirus infection

  1991cited by this paper
• Protection from rotavirus reinfection: 2-year prospective study.

  1991cited by this paper
• Rhesus Rotavirus candidate vaccine. Clinical trial in children vaccinated between 2 and 5 months of age.

  1990cited by this paper
• Molecular epidemiology of rotavirus in children attending day care centers in Houston.

  1990cited by this paper
• Development of an adult mouse model for studies on protection against rotavirus

  1990cited by this paper
• Development of an adult mouse model for studies on protection against rotavirus.

  1990cited by this paper
• Evaluation of WC3 Rotavirus Vaccine and Correlates of Protection in Healthy Infants

  1990cited by this paper
• Prospective study of diarrheal diseases in Venezuelan children to evaluate the efficacy of rhesus rotavirus vaccine

  1990cited by this paper
• Rotavirus-specific cytotoxic T lymphocytes passively protect against gastroenteritis in suckling mice

  1990cited by this paper
• An efficacy trial of the rhesus rotavirus vaccine in Maryland. The Clinical Study Group.

  1990cited by this paper
• Recovery from chronic rotavirus infection in mice with severe combined immunodeficiency: virus clearance mediated by adoptive transfer of immune CD8+ T lymphocytes

  1990cited by this paper
• Epidemiology of rotavirus infection and gastroenteritis in prospectively monitored Argentine families with young children.

  1989cited by this paper
• An observational study of naturally acquired immunity to rotaviral diarrhea in a cohort of 363 Egyptian children. Calculation of risk for second episodes using age-specific person-years of observation.

  1989cited by this paper
• Rotavirus VP7 neutralization epitopes of serotype 3 strains.

  1989cited by this paper
• Effects of antibody to rotavirus on protection of adults challenged with a human rotavirus.

  1989cited by this paper
• Protection of Peruvian children against rotavirus diarrhea of specific serotypes by one, two, or three doses of the RIT 4237 attenuated bovine rotavirus vaccine.

  1989cited by this paper
• Passive protection against rotavirus-induced diarrhea by monoclonal antibodies to the heterotypic neutralization domain of VP7 and the VP8 fragment of VP4

  1989cited by this paper
• Local and systemic antibody response to rotavirus WC3 vaccine in adult volunteers.

  1989cited by this paper
• Epidemiology of rotavirus subgroups and serotypes in Belem, Brazil: a three-year study.

  1988cited by this paper
• Relative concentrations of serum neutralizing antibody to VP3 and VP7 proteins in adults infected with a human rotavirus

  1988cited by this paper
• Protective Effect of WC3 Vaccine Against Rotavirus Diarrhea in Infants During a Predominantly Serotype 1 Rotavirus Season

  1988cited by this paper
• Comparative analysis of the VP3 gene of divergent strains of the rotaviruses simian SA11 and bovine Nebraska calf diarrhea virus

  1988cited by this paper
• Infection immunity of piglets to either VP3 or VP7 outer capsid protein confers resistance to challenge with a virulent rotavirus bearing the corresponding antigen

  1988cited by this paper
• Two sequential outbreaks of rotavirus gastroenteritis: evidence for symptomatic and asymptomatic reinfections.

  1988cited by this paper
• Prospective longitudinal study of rotavirus infections in children from birth to two years of age in Central Africa.

  1988cited by this paper
• Horse reservoir for Borrelia burgdorferi?

  1987cited by this paper
• Avirulent rotavirus infections protect calves from disease with and without inducing high levels of neutralizing antibody.

  1987cited by this paper
• Neutralizing antibody response of gnotobiotic piglets after fetal infection and neonatal challenge with human rotavirus strains.

  1987cited by this paper
• Protection between different serotypes of bovine rotavirus in gnotobiotic calves: specificity of serum antibody and coproantibody responses

  1987cited by this paper
• Trial of an attenuated bovine rotavirus vaccine (RIT 4237) in Gambian infants.

  1987cited by this paper
• Failure of live, attenuated oral rotavirus vaccine.

  1986cited by this paper
• Reassortant rotaviruses containing structural proteins vp3 and vp7 from different parents induce antibodies protective against each parental serotype

  1986cited by this paper
• Cultivation and characterization of three strains of murine rotavirus

  1986cited by this paper
• Passive protection against rotavirus-induced diarrhea by monoclonal antibodies to surface proteins vp3 and vp7

  1986cited by this paper
• Heterologous protection against rotavirus-induced disease in gnotobiotic piglets

  1986cited by this paper
• Human rotavirus studies in volunteers: determination of infectious dose and serological response to infection.

  1986cited by this paper
• Diarrheal response of gnotobiotic pigs after fetal infection and neonatal challenge with homologous and heterologous human rotavirus strains

  1986cited by this paper
• Protective effect of naturally acquired homotypic and heterotypic rotavirus antibodies.

  1986cited by this paper
• Protection against rotavirus-induced gastroenteritis in a murine model by passively acquired gastrointestinal but not circulating antibodies

  1985cited by this paper
• Effect of mutation in immunodominant neutralization epitopes on the antigenicity of rotavirus SA-11.

  1985cited by this paper
• Evidence of immunity induced by naturally acquired rotavirus and Norwalk virus infection on two remote Panamanian islands.

  1985cited by this paper
• Protection of infants against rotavirus diarrhoea by RIT 4237 attenuated bovine rotavirus strain vaccine.

  1984cited by this paper
• Epidemiology of rotaviruses in a cohort of 45 Guatamalan Mayan Indian children observed from birth to the age of three years.

  1983cited by this paper
• Clinical immunity after neonatal rotavirus infection. A prospective longitudinal study in young children.

  1983cited by this paper
• Definition of human rotavirus serotypes by plaque reduction assay

  1982cited by this paper
• Acquisition of serum antibody to Norwalk Virus and rotavirus and relation to diarrhea in a longitudinal study of young children in rural Bangladesh.

  1982cited by this paper
• Rotaviral immunity in gnotobiotic calves: heterologous resistance to human virus induced by bovine virus.

  1979cited by this paper
• Epidemiology of human rotavirus Types 1 and 2 as studied by enzyme-linked immunosorbent assay.

  1978cited by this paper
• Letter: Medical control over labour.

  1975cited by this paper
• WRINKLING OF SKIN IN CYSTIC FIBROSIS

  1974cited by this paper
• Acute transverse myelitis complicating pneumonia; report of a case.

  1948cited by this paper

• Enzyme-linked immunosorbent assay to determine the potency of a rotavirus vaccine based on virus-like particles: analytical procedure development and validation

  2024cites this paper
• Probiotic as Adjuvant Significantly Improves Protection of the Lanzhou Trivalent Rotavirus Vaccine against Heterologous Challenge in a Gnotobiotic Pig Model of Human Rotavirus Infection and Disease

  2022cites this paper
• Comparative In Vitro and In Vivo Studies of Porcine Rotavirus G9P[13] and Human Rotavirus Wa G1P[8]

  2015cites this paper
• 1 Is Associated With Induction of b-Cell Autoimmunity That Portends Type 1 Diabetes

  2014cites this paper
• Coxsackievirus B1 Is Associated With Induction of β-Cell Autoimmunity That Portends Type 1 Diabetes

  2014cites this paper
• Prevention of cholestasis in the murine rotavirus-induced biliary atresia model using passive immunization and nonreplicating virus-like particles.

  2013cites this paper
• Effects of supplemental osteopontin on intestinal development and serum antibody responses to rotavirus vaccination in piglets

  2011cites this paper
• Immune Mediators of Rotavirus Antigenemia Clearance in Mice

  2011cites this paper
• Why does the world need another rotavirus vaccine?

  2008cites this paper
• Rotaviruses: Immunological Determinants of Protection Against Infection and Disease

  2008influential citation
• Individuals with selective IgA deficiency resolve rotavirus disease and develop higher antibody titers (IgG, IgG1) than IgA competent individuals

  2008cites this paper
• To serotype or not to serotype: that is still the question.

  2007cites this paper
• PRESENT STATUS OF ROTA VIRUS VACCINE

  2007cites this paper
• Live attenuated human rotavirus vaccine, Rotarix.

  2006cites this paper
• Protection against rotavirus shedding after intranasal immunization of mice with a chimeric VP6 protein does not require intestinal IgA.

  2006cites this paper
• Virology of the Gastrointestinal Tract

  2006cites this paper
• Mice Develop Effective but Delayed Protective Immune Responses When Immunized as Neonates either Intranasally with Nonliving VP6/LT(R192G) or Orally with Live Rhesus Rotavirus Vaccine Candidates

  2006cites this paper
• Rotarix: development of a live attenuated monovalent human rotavirus vaccine.

  2006cites this paper
• Evaluation of Serum Antibody Responses against the Rotavirus Nonstructural Protein NSP4 in Children after Rhesus Rotavirus Tetravalent Vaccination or Natural Infection

  2005cites this paper
• Oral immunization with pBsVP6-transgenic alfalfa protects mice against rotavirus infection.

  2005cites this paper
• Rotavirus vaccines and impact of maternal antibodies and cytokines on neonatal immune responses in swine.

  2005cites this paper
• Efficient intranasal immunization of newborn mice with recombinant adenovirus expressing rotavirus protein VP4 against oral rotavirus infection.

  2005cites this paper
• Discovery of a new strain of murine rotavirus that is consistently shed in large quantities after oral inoculation of adult mice.

  2004cites this paper
• Possible Mechanisms of Protection Elicited by Candidate Rotavirus Vaccines as Determined with the Adult Mouse Model

  2003cites this paper
• Protection and antibody responses to oral priming by attenuated human rotavirus followed by oral boosting with 2/6-rotavirus-like particles with immunostimulating complexes in gnotobiotic pigs.

  2003cites this paper
• II, 13. Current state of development of human rotavirus vaccines

  2003cites this paper
• II, 10. The rat model of rotavirus infection

  2003cites this paper
• Group A Rotavirus Infection and Age-Dependent Diarrheal Disease in Rats: a New Animal Model To Study the Pathophysiology of Rotavirus Infection

  2002cites this paper
• Inhibition of rotavirus replication by a non-neutralizing, rotavirus VP6-specific IgA mAb.

  2002cites this paper
• Distribution of rotavirus-specific memory B cells in gut-associated lymphoid tissue after primary immunization.

  2001cites this paper
• Evaluation of rotavirus vaccines in small animal models.

  2000cites this paper
• Simian rhesus rotavirus is a unique heterologous (non-lapine) rotavirus strain capable of productive replication and horizontal transmission in rabbits.

  2000cites this paper
• Rotavirus serotypes: classification and importance in epidemiology, immunity, and vaccine development.

  2000cites this paper
• Encapsulation of rotavirus into poly(lactide-co-glycolide) microspheres.

  1999cites this paper
• Antibody responses and protection stimulated by sequential oral-parenteral immunization of mice with rotavirus.

  1999cites this paper
• Adult Mouse Model for Rotavirus

  1999cites this paper
• Humoral and cell‐mediated immune responses in humans to the NSP4 enterotoxin of rotavirus

  1999cites this paper
• Antibody-Dependent and -Independent Protection following Intranasal Immunization of Mice with Rotavirus Particles

  1999cites this paper
• Effect of oral rotavirus/iscom vaccines on immune responses in gnotobiotic lambs.

  1999cites this paper
• Particle-bombardment-mediated DNA vaccination with rotavirus VP4 or VP7 induces high levels of serum rotavirus IgG but fails to protect mice against challenge.

  1998cites this paper
• Antibody-Secreting Cell Responses and Protective Immunity Assessed in Gnotobiotic Pigs Inoculated Orally or Intramuscularly with Inactivated Human Rotavirus

  1998cites this paper
• Safety and immunogenicity of live, attenuated human rotavirus vaccine 89-12.

  1998cites this paper
• Serum and intestinal isotype antibody responses and correlates of protective immunity to human rotavirus in a gnotobiotic pig model of disease.

  1998cites this paper
• The immunology of rotavirus infection in the mouse.

  1998cites this paper
• Characterisation of the primary local and systemic immune response in gnotobiotic lambs against rotavirus infection.

  1998cites this paper
• Stimulation of local immunity and protection in mice by intramuscular immunization with triple- or double-layered rotavirus particles and QS-21.

  1998cites this paper
• Subunit Rotavirus Vaccine Administered Parenterally to Rabbits Induces Active Protective Immunity

  1998cites this paper
• Rotavirus disease, but not infection and development of intestinal histopathological lesions, is age restricted in rabbits.

  1998cites this paper
• Evidence that resolution of rotavirus infection in mice is due to both CD4 and CD8 cell-dependent activities

  1997cites this paper
• Identification of a T-helper cell epitope on the rotavirus VP6 protein

  1997cites this paper
• Particle bombardment-mediated DNA vaccination with rotavirus VP6 induces high levels of serum rotavirus IgG but fails to protect mice against challenge.

  1997cites this paper
• Rotavirus virus-like particles administered mucosally induce protective immunity

  1997cites this paper
• Immunological Aspects of Viral Gastroenteritis

  1996cites this paper
• New strategies in oral immunotherapy for diabetes prevention.

  1996cites this paper
• New Lessons for Rotavirus Vaccines

  1996cites this paper
• Molecular determinants of immunity and pathogenicity of rotavirus infection in the mouse model.

  1996cites this paper
• Rotavirus vaccine: current status & future prospects.

  1996cites this paper
• Mechanisms of protection against rotavirus in humans and mice.

  1996cites this paper
• Waterborne rotavirus: A risk assessment

  1996cites this paper
• Systematic and intestinal antibody-secreting cell responses and correlates of protective immunity to human rotavirus in a gnotobiotic pig model of disease

  1996cites this paper
• Human immunity to rotavirus.

  1995cites this paper
• Role of B cells and cytotoxic T lymphocytes in clearance of and immunity to rotavirus infection in mice

  1995cites this paper
• Effector functions of antibody and CD8+ cells in resolution of rotavirus infection and protection against reinfection in mice.

  1995cites this paper
• Long-term production of rotavirus antibody and protection against reinfection following a single infection of neonatal mice with murine rotavirus.

  1995cites this paper
• Methods for assessing cell-mediated immunity in infectious disease resistance and in the development of vaccines.

  1995cites this paper
• Rotavirus pathology and pathophysiology.

  1994cites this paper
• Comparison of VP4 and VP7 of five murine rotavirus strains.

  1994cites this paper
• Species specificity and interspecies relatedness in VP4 genotypes demonstrated by VP4 sequence analysis of equine, feline, and canine rotavirus strains.

  1994cites this paper
• Active immunity against rotavirus infection in mice is correlated with viral replication and titers of serum rotavirus IgA following vaccination.

  1994cites this paper
• An immunodominant cytotoxic T cell epitope on the VP7 rotavirus protein overlaps the H2 signal peptide.

  1993cites this paper
• Studies on the role of VP4 of G serotype 10 rotavirus (B223) in the induction of the heterologous immune response in calves.

  1993cites this paper
• Genomic relatedness of five equine rotavirus strains with different G serotype and P type specificities.

  1993cites this paper
• Analysis of homotypic and heterotypic serum immune responses to rotavirus proteins following primary rotavirus infection by using the radioimmunoprecipitation technique

  1993cites this paper
• Immunodominance of the VP4 neutralization protein of rotavirus in protective natural infections of young children

  1993cites this paper
• Protective immunity to rotavirus-induced diarrhoea is passively transferred to newborn mice from naive dams vaccinated with a single dose of a recombinant adenovirus expressing rotavirus VP7sc.

  1993cites this paper
• Active protection against rotavirus infection of mice following intraperitoneal immunization.

  1992cites this paper
• Evidence that protection against rotavirus diarrhea after natural infection is not dependent on serotype-specific neutralizing antibody.

  1992cites this paper